Taking care of immune-beneficial infant gut bacteria
Published in Microbiology
It's 11:40 PM of an unexpectedly long day when Samanta and I are submitting the rebuttal of our paper: A reverse metabolic approach to weaning: in silico identification of immune-beneficial infant gut bacteria, mining their metabolism for prebiotic feeds and sourcing these feeds in the natural product space. We are in the middle of an extremely intense period, but we are committed to meet the deadline, as the results are part of the New Zealand trial "Nourish to Flourish": forty babies and their mothers took part in this study, which will follow the little ones until they turn one.
The project began a couple of years earlier, when COSBI and The Liggins Institute thought about a radically different way to approach nutrition studies, compared to traditional ones, and started a fruitful collaboration. Having identified the research goal, which is to improve infant immune health, we designed and developed an in silico Systems Nutrition strategy. The health benefit we look for with an improvement of the immune system is the reduction in the incidence of infections around weaning.
Human gut is host to the largest part of our immune system and this is not surprising when we think about our intestine not as an inner organ but as the sheltering conduct where the external environment transits through our bodies. Since we are born, and even before, gut and external microbes evolve and co-exist with the immune cells and this interaction, ultimately leading to the immune system “training”, is even well recognized in our everyday decisions based on a “gut feeling”. The immune system gets exposed to a variety of substances: dirt, allergens and environmental factors that help recognizing what is tolerable from what needs to be fought. This education is crucial to avoid unneeded over-responses or lacking defenses all along our lives. Gut bacteria ecosystem represents a huge variety of what we can commonly refer to as “good” and “bad” microorganisms that eventually need to come to a balance with our immune system.
Our research began identifying in silico, which means by advanced mining of public domain literature, infant gut microbes that could strengthen the immune system. Our starting point was the scientific literature where a search on ‘microbiome’ yielded more than 47,000 PubMed articles. Therefore our first need was to concentrate the efforts on those articles concerning the beneficial role of gut microbes on the infant immune system and infections prevention during weaning. We built specific queries to find only the relevant literature. Then we developed and applied natural language processing methods (NLP) in a multi-level text-mining pipeline to extract only the relevant sentences. We went from thousands of papers to hundreds of informative sentences. From these sentences, the gut microbes names were automatically recognized and extracted, resulting in 18 putative probiotics, selected for their contribution to the immune system development and their presence in the infant gut.
To promote and take care of these “good” bacteria we wanted to find out how we could feed their nutritional requirements: the so-called exogenous metabolites that represent their potential prebiotic food. This means that those metabolites cannot be produced by metabolic reactions, but they have to be provided from the environment, in this case the infant gastro-intestinal tract. To stimulate the growth of the health-beneficial gut bacteria (probiotics) the introduction of prebiotics into the diet is in fact a common procedure. Prebiotics are foods that can positively stimulate gut microbes harbored by the human colon. The nutrient profile of our candidate probiotic community was analyzed and, using a metabolic network topology approach, we identified the metabolites that are exogenously required by every microbe in the community.
Considering the exogenous compounds are both lacking and subject to bacteria competition, they are effectively limiting elements for the growth of our candidate microbes. So, we searched for these prebiotics in the form of complementary foods that could supply limiting nutrients to the community and positively modulate the infant gut composition. We mined specific databases to search for these essential metabolites into the natural food space. The obtained list of foods was manually screened to exclude clearly inadequate weaning aliments such as processed foods and alcoholic and we ranked them according to their efficiency in stimulating bacteria growth.
This unbiased approach led to identifying a range of natural foods satisfying our goal of an increased immune-beneficial gut microflora in humans, but the aliments had to be assessed by the nutritionists in our team with screening criteria that clearly included the adherence to pediatric recommendations. For example, while honey was the top hit, using it as a complementary food is controversial (in particular raw honey) or likewise for peanuts and meat which may come with age-specific recommendations. Among all the foods showing the highest amounts of essential vitamins and amino acids, the Kumara (New Zealand sweet potato) appeared a success as it is a practical choice for the formulation of infant complementary foods, besides a New Zealand product. Kumara powder was therefore proposed for the High-Value Nutrition National Science Challenge pilot clinical trials on infants aged 6–12 months, where each subject will receive a fixed quantity that could be mixed with the infant’s complementary foods.
The different steps of our pipeline required a very vast and varied expertise and involved different ‘players’ within our multidisciplinary and multinational team (microbiologists, bioinformatics and nutritionists). The overall research was scientifically and personally rewarding, and all the team is looking forward to the completion of the clinical trials that are adopting, while writing, the foods identified in the study to help validate this approach.
Follow the Topic
-
Microbiome
This journal hopes to integrate researchers with common scientific objectives across a broad cross-section of sub-disciplines within microbial ecology. It covers studies of microbiomes colonizing humans, animals, plants or the environment, both built and natural or manipulated, as in agriculture.
Related Collections
With Collections, you can get published faster and increase your visibility.
Oncobiome
This collection of papers delves into the burgeoning field of oncobiome research, exploring the intricate relationship between cancer and the microbiome. The oncobiome encompasses the diverse microbial communities residing in and on the human body, which influence cancer development, progression, and treatment responses. By examining these interactions, our aim is to unravel the complex mechanisms through which the microbiome impacts oncogenesis and therapeutic outcomes.
This compilation highlights cutting-edge research, offering insights into potential diagnostic markers and novel therapeutic strategies, thereby advancing our understanding of cancer biology and paving the way for innovative, microbiome-targeted cancer treatments.
This is a cross-journal collection between:
Experimental Hematology and Oncology
Articles will undergo the standard peer-review process of the journal to which they are submitted and are subject to either the BMC editorial policies or those of BJC Reports. Articles will be added to the Collection as they are published. The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.
Publishing Model: Open Access
Deadline: Ongoing
The Apple Microbiome
Microbiome and Environmental Microbiome are calling for submissions to our Collection on the Apple Microbiome.
With world apple production estimated at 84 million tons, the microbiome of the apple has significant implications for agriculture, food security, and human health. Understanding the complex interactions between apple plants and their associated microbial communities can lead to improved crop management strategies, enhanced fruit quality and longevity, and sustainable agricultural practices. Recent advances have highlighted the role of specific bacteria and fungi in promoting plant health and resilience against specific pathogens. Moreover, detailed profiling of these microbial communities, revealing their diversity and functional potential facilitate exciting future developments, such as the identification of beneficial microbial consortia for biocontrol and the formulation of tailored probiotic treatments for both plants and humans. By advancing our collective understanding in this area, we can work towards a more sustainable and resilient agricultural system.
Topics of interest include but are not limited to:
-Microbial diversity and function associated with apples
-Effects of soil health and rhizosphere interactions on apple production
-Impact of climate change on the apple microbiome
-Role of the apple microbiome in fruit quality
-Microbiome-driven strategies for disease resistance
This collection is open for submissions from all authors on the condition that the manuscript falls within both the scope of the collection and the journal it is submitted to.
All submissions in this collection undergo the relevant journal’s standard peer review process. Similarly, all manuscripts authored by a Guest Editor(s) will be handled by the Editor-in-Chief of the relevant journal. As an open access publication, participating journals levy an article processing fee (Microbiome, Environmental Microbiome). We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or the Editor-in-Chief of the journal where the article is being submitted.
Publishing Model: Open Access
Deadline: Sep 30, 2026